← Eichor
Study identifier: NCT06569953 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

Condition: Acute Pain · Chronic Pain · Postoperative Pain  ·  Sponsor: The Second Affiliated Hospital of Chongqing Medical University

PhasePhase 4
Planned participants284
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the efficacy and safety of liposomal Bupivacaine administered by paravertebral block for the treatment of acute and chronic pain after video-assisted thoracoscopic lobectomy.

This description comes directly from the study's public registry record.

Talk to the study team

He Huang, ph.D  ·  86+13708385559  ·  huanghe@cqmu.edu.cn

Guangyou Duan, ph.D  ·  86+18323376014  ·  duangy@hospital.cqmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The Second Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06569953